In this week's second major AI model launch for life sciences research, OpenAI has introduced GPT-Rosalind, designed to accelerate drug discovery and support biology-related research work. The launch ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

NASA confirmed Thursday that SpaceX will launch the European Space Agency’s Rosalind Franklin Mars rover, perhaps as soon as late 2028, on a Falcon Heavy rocket from Kennedy Space Center, Florida. So ...

I'm a Fitness & Nutrition writer for CNET who enjoys reviewing the latest fitness gadgets, testing out activewear and sneakers, as well as debunking wellness/fitness myths. In my free time I enjoy ...

NASA has approved its Rosalind Franklin Support and Augmentation (ROSA) project for the Rosalind Franklin rover mission to Mars. This step clears the way for the US space agency to begin delivering ...

NASA has confirmed the pending launch of the European Space Agency's (ESA) Rosalind Franklin rover, which is being sent to Mars. The current plan is to launch via a SpaceX Falcon Heavy rocket from ...

OpenAI on Thursday introduced an artificial intelligence model touting increased biology knowledge and scientific research capabilities, as ‌the startup deepens its push into the life sciences field.

The GPT-Rosalind model builds on OpenAI’s newest internal models with enhanced tool use, database integration, and domain-specific knowledge. OpenAI is expanding into scientific research with the ...

OpenAI has launched a new artificial intelligence model designed to support research across biology, drug discovery, and translational medicine. The new tool, called GPT-Rosalind, is named after ...

NASA is moving ahead with its contribution to the European Space Agency's (ESA) long-delayed Rosalind Franklin Mars rover despite another attempt by the Trump administration to cut funding for the ...

Shares of leading life sciences companies will be in focus on Friday after OpenAI launched GPT-Rosalind, an AI model designed to accelerate drug discovery and support biology-related research work. In ...

Following its recently announced partnership with Novo Nordisk, OpenAI is introducing a new reasoning model, GPT-Rosalind, to support research in biology, drug discovery and translational medicine.